The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Hussin A Rothan, Siddappa N Byrareddy, Hussin A Rothan, Siddappa N Byrareddy

Abstract

Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease.

Keywords: COVID-19; Coronavirus; Pathogenesis; Pneumonia; Wuhan city.

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest.

Copyright © 2020 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
The chronological incidence of COVID-19 infections and death cases in China. Infections with COVID-19 appears in December 2019. At the time of preparing this manuscript, February 16, 2020 there have been 51,174 people who have contracted the infection in China, and more than 1666 people have died.
Fig. 2
Fig. 2
The systemic and respiratory disorders caused by COVID-19 infection. The incubation period of COVID-19 infection is approximately 5.2 days. There are general similarities in the symptoms between COVID-19 and previous betacoronavirus. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat. Additionally, patients infected with COVID-19 developed intestinal symptoms like diarrhoea only a low percentage of MERS-CoV or SARS-CoV patients exhibited diarrhoea.

References

    1. Bogoch, Watts A., Thomas-Bachli A., Huber C., Kraemer M.U.G., Khan K. Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel. J. Trav. Med. 2020 doi: 10.1093/jtm/taaa008.
    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle. J. Med. Virol. 2020;92(4):401–402. doi: 10.1002/jmv.25678.
    1. Zhao S., Lin Q., Ran J., Musa S.S., Yang G., Wang W. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int. J. Infect. Dis. : IJID : Off. Publ. Int. Soc. Infect. Dis. 2020;92:214–217. doi: 10.1016/j.ijid.2020.01.050.
    1. Du Toit A. Outbreak of a novel coronavirus. Nat. Rev. Microbiol. 2020;18(123) doi: 10.1038/s41579-020-0332-0.
    1. Ren L.L., Wang Y.M., Wu Z.Q., Xiang Z.C., Guo L., Xu T. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Med J. 2020 doi: 10.1097/CM9.0000000000000722.
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
    1. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci. Trends. 2020 doi: 10.5582/bst.2020.01020.
    1. Wang W., Tang J., Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol. 2020;92(4):441–447. doi: 10.1002/jmv.25689.
    1. Nishiura H., Jung S.M., Linton N.M., Kinoshita R., Yang Y., Hayashi K. The extent of transmission of novel coronavirus in wuhan, China, 2020. J. Clin. Med. 2020;9
    1. Bassetti M., Vena A., Roberto Giacobbe D. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. Eur. J. Clin. Invest. 2020 doi: 10.1111/eci.13209.
    1. Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001191.
    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001316.
    1. Carlos W.G., Dela Cruz C.S., Cao B., Pasnick S., Jamil S. Novel wuhan (2019-nCoV) coronavirus. Am. J. Respir. Crit. Care Med. 2020;201(4):7–8. doi: 10.1164/rccm.2014P7.
    1. Lei J., Li J., Li X., Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020:200236. doi: 10.1148/radiol.2020200236.
    1. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013;13:752–761.
    1. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003;348:1986–1994.
    1. Phan L.T., Nguyen T.V., Luong Q.C., Nguyen T.V., Nguyen H.T., Le H.Q. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2001272.
    1. Ji W., Wang W., Zhao X., Zai J., Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J. Med. Virol. 2020;92(4):433–440. doi: 10.1002/jmv.25682.
    1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8.
    1. Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020 doi: 10.1128/JVI.00127-20.
    1. Wu P., Hao X., Lau E.H.Y., Wong J.Y., Leung K.S.M., Wu J.T. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25
    1. Jaimes J.A., Millet J.K., Stout A.E., Andre N.M., Whittaker G.R. A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses. 2020;12
    1. Hui D.S., IA E., Madani T.A., Ntoumi F., Kock R., Dar O. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264–266.
    1. Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192.
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2019;382:727–733. doi: 10.1056/NEJMoa2001017. 2020.
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7.
    1. Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M. Cell research; 2020. Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro.
    1. Toots M., Yoon J.J., Cox R.M., Hart M., Sticher Z.M., Makhsous N. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Transl. Med. 2019:11.
    1. Jin Y.H., Cai L., Cheng Z.S., Cheng H., Deng T., Fan Y.P. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil. Med. Res. 2020;7:4.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe